Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soha Pharmaceutical is a leading Iranian pharmaceutical manufacturer and a key subsidiary of the Medical Procurement Organization of the Red Crescent Society of the Islamic Republic of Iran. Established to enhance national self-sufficiency in medicine, the company operates one of the largest and most advanced pharmaceutical production sites in the region, located in the Alborz province. Its extensive product portfolio includes a wide range of generic medications in solid dosage forms, such as tablets and capsules, targeting therapeutic areas like cardiology, gastroenterology, and infectious diseases. The company adheres to international Good Manufacturing Practice (GMP) standards to ensure the quality and safety of its products for both domestic and export markets. Soha Pharmaceutical plays a vital role in the Iranian healthcare infrastructure by providing affordable essential medicines to the public. The facility is equipped with modern laboratories for quality control and research and development to maintain high standards of pharmaceutical excellence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soha Pharmaceuticals.